BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22798321)

  • 1. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.
    Charlson ES; Diamond JM; Bittinger K; Fitzgerald AS; Yadav A; Haas AR; Bushman FD; Collman RG
    Am J Respir Crit Care Med; 2012 Sep; 186(6):536-45. PubMed ID: 22798321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.
    Simon-Soro A; Sohn MB; McGinniss JE; Imai I; Brown MC; Knecht VR; Bailey A; Clarke EL; Cantu E; Li H; Bittinger K; Diamond JM; Christie JD; Bushman FD; Collman RG
    Ann Am Thorac Soc; 2019 Nov; 16(11):1383-1391. PubMed ID: 31415219
    [No Abstract]   [Full Text] [Related]  

  • 3. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome.
    Willner DL; Hugenholtz P; Yerkovich ST; Tan ME; Daly JN; Lachner N; Hopkins PM; Chambers DC
    Am J Respir Crit Care Med; 2013 Mar; 187(6):640-7. PubMed ID: 23328523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
    Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis.
    Kabbani D; Bhaskaran A; Singer LG; Bhimji A; Rotstein C; Keshavjee S; Liles WC; Husain S
    J Heart Lung Transplant; 2017 Sep; 36(9):973-979. PubMed ID: 28487045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.
    Dickson RP; Erb-Downward JR; Freeman CM; Walker N; Scales BS; Beck JM; Martinez FJ; Curtis JL; Lama VN; Huffnagle GB
    PLoS One; 2014; 9(5):e97214. PubMed ID: 24831685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchiolitis obliterans syndrome susceptibility and the pulmonary microbiome.
    Schott C; Weigt SS; Turturice BA; Metwally A; Belperio J; Finn PW; Perkins DL
    J Heart Lung Transplant; 2018 Sep; 37(9):1131-1140. PubMed ID: 29929823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
    Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
    Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection.
    Påhlman LI; Manoharan L; Aspelund AS
    Respir Res; 2021 Apr; 22(1):118. PubMed ID: 33892717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection in lung transplantation].
    Gavaldà J; Román A
    Enferm Infecc Microbiol Clin; 2007 Dec; 25(10):639-49; quiz 650. PubMed ID: 18053475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
    Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
    Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of gram-positive infections in lung transplantation.
    Gupta MR; Valentine VG; Walker JE; Lombard GA; LaPlace SG; Seoane L; Taylor DE; Dhillon GS
    Transpl Infect Dis; 2009 Oct; 11(5):424-31. PubMed ID: 19659672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topographical continuity of bacterial populations in the healthy human respiratory tract.
    Charlson ES; Bittinger K; Haas AR; Fitzgerald AS; Frank I; Yadav A; Bushman FD; Collman RG
    Am J Respir Crit Care Med; 2011 Oct; 184(8):957-63. PubMed ID: 21680950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
    Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.
    Cui L; Lucht L; Tipton L; Rogers MB; Fitch A; Kessinger C; Camp D; Kingsley L; Leo N; Greenblatt RM; Fong S; Stone S; Dermand JC; Kleerup EC; Huang L; Morris A; Ghedin E
    Am J Respir Crit Care Med; 2015 Apr; 191(8):932-42. PubMed ID: 25603113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts.
    Charlson ES; Bittinger K; Chen J; Diamond JM; Li H; Collman RG; Bushman FD
    PLoS One; 2012; 7(9):e42786. PubMed ID: 22970118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance bronchoscopy in lung transplant recipients: risk versus benefit.
    McWilliams TJ; Williams TJ; Whitford HM; Snell GI
    J Heart Lung Transplant; 2008 Nov; 27(11):1203-9. PubMed ID: 18971092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.